How to taper off metoprolol (beta blocker) and initiate an Angiotensin-Converting Enzyme (ACE) inhibitor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Transitioning from metoprolol to an ACE inhibitor should be done gradually under medical supervision, with a slow reduction of metoprolol dose over 1-2 weeks while monitoring blood pressure and heart rate, followed by initiation of the ACE inhibitor at a low dose and gradual increase as needed, as recommended by the most recent guidelines 1. When tapering off metoprolol, it's essential to monitor blood pressure and heart rate closely to avoid rebound hypertension or worsening angina. The metoprolol dose can be reduced by half every few days, for example, from 50mg twice daily to 25mg twice daily, then to 25mg once daily, before stopping completely. Once metoprolol is discontinued, the ACE inhibitor can be started at a low dose, such as lisinopril 2.5-5mg once daily, and increased gradually every 2-4 weeks as needed and tolerated, up to a maximum dose of 10-40mg daily, as recommended by the European Society of Cardiology guidelines 1. The key considerations during this transition include:

  • Monitoring blood pressure, renal function, and electrolytes regularly, especially after each dose increment
  • Avoiding excessive diuresis before treatment and reducing or withholding diuretics if necessary
  • Starting treatment in the evening, if possible, to minimize potential negative effects on blood pressure
  • Avoiding potassium-sparing diuretics and non-steroidal anti-inflammatory drugs (NSAIDs) during initiation of therapy
  • Checking blood chemistry, including urea, creatinine, and potassium, 1-2 weeks after initiation and 1-2 weeks after final dose titration, and monitoring blood chemistry 4 monthly thereafter, as recommended by the guidelines 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.